BioCentury
ARTICLE | Politics & Policy

BIO, PhRMA release ads stressing value of innovation

February 9, 2016 1:24 AM UTC

BIO unveiled a one-minute advertisement and a new Acorda Therapeutics Inc. (NASDAQ:ACOR) and chairman of BIO, told BioCentury the trade group would soon begin a media and lobbying campaign emphasizing the value of biopharmaceuticals and the high costs of other healthcare products and services (see BioCentury, Jan. 18).

A BIO spokesperson told BioCentury the organization expects to spend "in the mid-to-high six figures" on this stage of the campaign, and said the campaign's website will include "multiple voices" including those of patients and other stakeholders. ...